# A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

Study · id `cardio:ct-nct07188805` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07188805](<https://clinicaltrials.gov/study/NCT07188805>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07188805

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 111 participants.

## Technical summary

Registry record NCT07188805. Randomized; triple masking; primary purpose treatment. Start 2025-11-19 (actual); primary completion 2029-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 111 participants (planned count; ClinicalTrials.gov record NCT07188805, source copy `cardio:ctgov-nct07188805-2026-10-15`, retrieved 2026-10-26)
- Started: 2025-11-19 (actual) (ClinicalTrials.gov record NCT07188805, source copy `cardio:ctgov-nct07188805-2026-10-15`, retrieved 2026-10-26)
- Primary completion: 2029-11-30 (anticipated) (ClinicalTrials.gov record NCT07188805, source copy `cardio:ctgov-nct07188805-2026-10-15`, retrieved 2026-10-26)
- Completion: 2029-12-30 (anticipated) (ClinicalTrials.gov record NCT07188805, source copy `cardio:ctgov-nct07188805-2026-10-15`, retrieved 2026-10-26)
- Countries: United States; Argentina; Austria; Belgium; Brazil; Bulgaria; Canada; Czechia; Finland; Germany; Greece; Hungary; Israel; Italy; Mexico; Poland; Portugal; South Korea; Spain; Sweden; Taiwan; Türkiye; United Kingdom (ClinicalTrials.gov record NCT07188805, source copy `cardio:ctgov-nct07188805-2026-10-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07188805-2026-10-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Acronym: FIORE
- Condition: Left Ventricular Systolic Dysfunction
- Condition: Heart Failure (Pediatric)
- Intervention (Drug): Finerenone (Kerendia, BAY94-8862)
- Intervention (Drug): Placebo
- Lead sponsor: Bayer
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Finerenone (`cardio:finerenone`)
- Registry intervention is a member of this class by a sourced record link: Mineralocorticoid receptor antagonists (drug class) (`cardio:mineralocorticoid-receptor-antagonists`)
- Registry lists this organization as the lead sponsor: Bayer (`cardio:bayer`)

## Provenance

Content hash: 17821fb1388534fc6d7c2fe5b843e336020f0c4814118e039e3b6ac97b5d8e64
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
